Activatable particles, preparation and uses
AssigneeNanobiotix
InventorsLaurent Levy, Jean-Francois Hochepied, Jeremy Balencie, Paras Nath Prasad, Earl Jim Bergey, Edouard Andre Panak, Abdel Kader Boussaha
Life of this patent
Estimating the term…
Loading patent…
AssigneeNanobiotix
InventorsLaurent Levy, Jean-Francois Hochepied, Jeremy Balencie, Paras Nath Prasad, Earl Jim Bergey, Edouard Andre Panak, Abdel Kader Boussaha
Estimating the term…
The present invention relates to novel activatable particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals or heat when excited by X rays, and to the uses thereof in health, particularly human. The inventive particles comprise an inorganic-based, and optionally organic-based, nucleus and can be activated in vivo, in order to label or alter cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or diagnostic compositions containing same.
A method for inducing the lysis or destruction of cancer cells, in vitro, ex vivo or in vivo, comprising (i) contacting cancer cells with one or more biocompatible composite particles or nanoparticle aggregates which can generate free radicals or heat when excited by X rays applied by using a system of radiotherapy or radiography, each of said biocompatible composite particle comprising
A method of cancer treatment, comprising (i) administering biocompatible composite particles or nanoparticle aggregates, which can generate free radicals or heat when excited by X rays applied by using a system of radiotherapy or radiography, to a patient suffering from a cancer, each of said biocompatible composite particle comprising:
A method of cancer treatment, comprising (i) administering a composition comprising biocompatible composite particles or nanoparticle aggregates, which can generate free radicals or heat when excited by X rays applied by using a system of radiotherapy or radiography, to a patient suffering from a cancer, each of said biocompatible composite particle comprising:
Dependencies are inferred from the claim text.